Quarterly report pursuant to Section 13 or 15(d)

NOTE RECEIVABLE, RELATED PARTY, NET (Details Narrative)

v3.21.2
NOTE RECEIVABLE, RELATED PARTY, NET (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Apr. 30, 2019
Aug. 31, 2020
Jul. 31, 2021
Apr. 30, 2020
Apr. 10, 2018
Discounted Future Net Cash Flows Relating to Proved Oil and Gas Reserves [Line Items]          
Warrant terms     3 years 3 months 18 days    
Outstandinf receivable amount     $ 14,883,295    
Avalanche International Corp [Member] | Promissory Note [Member]          
Discounted Future Net Cash Flows Relating to Proved Oil and Gas Reserves [Line Items]          
Principal amount       $ 100,915 $ 995,500
Interest rate 10.00%        
Percentage of original issue discount 10.00%        
Original issue discount     $ 90,500    
Ault Life Sciences Fund L L C [Member] | Securities Purchase Agreement [Member]          
Discounted Future Net Cash Flows Relating to Proved Oil and Gas Reserves [Line Items]          
Principal amount   $ 50,000      
Interest rate   8.00%      
Number of shares purchase (in shares) 10,000,000        
Number of shares purchase $ 15,000,000        
Ault Life Sciences Fund L L C [Member] | Securities Purchase Agreement [Member] | Warrant [Member]          
Discounted Future Net Cash Flows Relating to Proved Oil and Gas Reserves [Line Items]          
Number of shares purchase (in shares)   16,667      
Number of warrants granted 5,000,000        
Warrant terms 5 years        
Exercise price (in dollars per share) $ 3.00 $ 3.00